{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-055180","form_type":"8-K","ticker":"LQDA","cik":"0001819576","company_name":"Liquidia Corp","filed_at":"2025-06-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.878214+00:00","generated_at":"2026-05-20T03:12:01.660911+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Liquidia starts YUTREPIA shipments after FDA approval; court denies UTHR injunction","bullets":["First commercial shipment of YUTREPIA (treprostinil) inhalation powder to specialty pharmacies scheduled.","FDA approved YUTREPIA on May 23, 2025 for PAH and PH-ILD.","Court denied United Therapeutics' motion for preliminary injunction and TRO on May 30, 2025.","Court concluded UTHR unlikely to succeed on merits; Liquidia's motion to dismiss remains pending.","CEO cites rapid launch: sales force active, product listed with compendia within one week."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-055180","json":"https://secwatch.observer/filing/0001104659-25-055180.json","markdown":"https://secwatch.observer/filing/0001104659-25-055180.md","text":"https://secwatch.observer/filing/0001104659-25-055180.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925055180/0001104659-25-055180-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1819576/000110465925055180/tm2516834d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T03:12:01.660911+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}